Racial/ethnic differences in eligibility for asthma biologics among pediatric populations
Open Access
- 16 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 148 (5) , 1324-1331.e12
Abstract
No abstract availableKeywords
Funding Information
- Genentech Inc
- Tobacco-Related Disease Research Program
- Sandler Foundation
- American Asthma Foundation
- National Institute of Public Health and the Environment
- US Food and Drug Administration
- National Heart Lung and Blood Institute
- National Institute of General Medical Sciences
This publication has 42 references indexed in Scilit:
- Impact of Race on Asthma Treatment Failures in the Asthma Clinical Research NetworkAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE NetworkHuman Genetics, 2011
- Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City ChildrenNew England Journal of Medicine, 2011
- Differences in Albuminuria Between Hispanics and Whites: An Evaluation by Genetic Ancestry and Country of OriginCirculation: Cardiovascular Genetics, 2010
- Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines GenePLOS Genetics, 2009
- The Predictive Value of IgE as Biomarker in AsthmaJournal of Asthma, 2008
- Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapyEuropean Respiratory Review, 2007
- Ethnic-Specific Differences in Bronchodilator Responsiveness Among African Americans, Puerto Ricans, and Mexicans with AsthmaJournal of Asthma, 2007
- Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthmaAnnals of Allergy, Asthma & Immunology, 2005
- Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop®)Allergy, 1998